The 18-month extension of the GATHER2 trial indicated continued benefit for patients receiving avacincaptad pegol, with ...
Ahead of the 2025 American Academy of Ophthalmology (AAO) meeting, the Eye Care Network spoke with Peter Stalmans, MD, PhD, ...
The study analyzed real-world treatment patterns and safety of avacincaptad pegol (ACP) for geographic atrophy using the IRIS ...
From the 2010s to the present, the existing technologies in the clinic and operating room have been improved with the goals ...
STAAR responded by saying, “We urge all STAAR stockholders not to be misled by Broadwood. STAAR is confident that the Alcon transaction maximizes value for STAAR stockholders [and] is the only merger ...
Ahead of the 2025 American Academy of Ophthalmology (AAO) meeting in Orlando, Florida, the Eye Care Network spoke with Jean-Francois Korobelnik, MD. Prof Korobelnik, of Hôpital Pellegrin and CHU de ...
Andrew G. Lee, MD, and Drew Carey, MD, highlight how chronic lymphocytic leukemia can mimic Graves’ orbitopathy, underscoring ...
The US Food and Drug Administration (FDA) has selected Abeona Therapeutics’ ABO-503 gene therapy for X-linked retinoschisis ...
Rayner's RayOne EMV Toric IOL received FDA approval after a successful pivotal IDE study, highlighting its rotational ...
BVI's FineVision HP trifocal IOL, approved by the FDA, enhances the US premium IOL market with advanced optic design for ...
Attendees of the AAO 2025 annual meeting will have a chance to preview the virtual technician training platform on October 19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback